Main Street Research LLC Biogen Inc. Transaction History

Main Street Research LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 29, 2020	SELL	$258.66 - $342.55 $14.4 Million - $19.1 Million	-55,689 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$268.85 - $341.04 $273,420 - $346,837	-1,017 Reduced 1.79%	55,689 $17.6 Million
Q4 2019 Jan 28, 2020	SELL	$220.06 - $304.07 $66,018 - $91,221	-300 Reduced 0.53%	56,706 $16.8 Million
Q3 2019 Oct 21, 2019	BUY	$217.44 - $243.88 $11 Million - $12.4 Million	50,656 Added 797.73%	57,006 $13.3 Million
Q2 2019 Aug 08, 2019	SELL	$219.29 - $241.72 $15,350 - $16,920	-70 Reduced 1.09%	6,350 $1.49 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $1.39 Million - $2.18 Million	6,420 New	6,420 $1.52 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $886,187 - $1.12 Million	-3,182 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$293.51 - $383.83 $31,699 - $41,453	-108 Reduced 3.28%	3,182 $1.12 Million
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $22,371 - $31,640	86 Added 2.68%	3,290 $901,000
Q4 2017 Feb 05, 2018	SELL	$307.64 - $344.58 $104,597 - $117,157	-340 Reduced 9.59%	3,204 $1.02 Million
Q3 2017 Oct 16, 2017	BUY	$281.15 - $329.69 $996,395 - $1.17 Million	3,544	3,544 $1.11 Million

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Main Street Research LLC, based on Form 13F filings with the SEC.

Stay updated on Main Street Research LLC with notifications on news.